Study Stopped
Low recruitment because patients and gynecologists prefer the sclerosis arm to avoid surgery
Anti-mullerian Hormone (AMH) After Treatment of Endometriomas With Alcohol Sclerotherapy Versus Surgery: Clinical Trial
Anti-mullerian Hormone in Ovarian Reserve Evaluation After Treatment of Endometriomas With Alcohol Sclerotherapy Versus Surgery: Clinical Trial
1 other identifier
interventional
158
1 country
1
Brief Summary
The purpose of this multicenter study is to compare the ovarian reserve after alcohol sclerosis of the endometriomas against conventional surgery (AMH, follicle stimulating hormone (FSH) and antral follicles count) as well as the complications and costs between the 2 procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 31, 2018
CompletedStudy Start
First participant enrolled
June 5, 2018
CompletedFirst Posted
Study publicly available on registry
June 28, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2023
CompletedMarch 2, 2023
February 1, 2023
4.6 years
May 31, 2018
February 28, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Change from Baseline AMH Test
the value of AMH in ng/mL
prior and 6 months after both procedures
Secondary Outcomes (4)
Change from Baseline antral follicles count
prior and 6 months after both procedures
Complications
1 month after the procedure
Costs
1 month after the procedure
Change from Baseline Pain
prior and 6 months after both procedures
Study Arms (2)
Surgery
ACTIVE COMPARATORLaparoscopic ovarian cystectomy
Sclerotherapy
ACTIVE COMPARATORUS-aspiration and alcohol sclerosis
Interventions
Eligibility Criteria
You may qualify if:
- Uni- or bilocular endometrioma according ultrasounds
- Endometrioma size: 30-100 mm when symptoms were present and 50-100 mm if asymptomatics
- \> 3 months from diagnosis
- Ca125 \<200 IU/mL and human epididymis protein 4 (HE4) \< 70,
You may not qualify if:
- Previous gynecological cancer
- Symptomatic severe extraovarian endometriosis
- Dermoid or high risk of malignancy cysts
- Pregnancy
- Mental disability
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital de Bellvitge
L'Hospitalet de Llobregat, Barcelona, 08907, Spain
Related Publications (11)
Coccia ME, Rizzello F, Cammilli F, Bracco GL, Scarselli G. Endometriosis and infertility Surgery and ART: An integrated approach for successful management. Eur J Obstet Gynecol Reprod Biol. 2008 May;138(1):54-9. doi: 10.1016/j.ejogrb.2007.11.010. Epub 2008 Feb 20.
PMID: 18243485BACKGROUNDMuzii L, Bianchi A, Croce C, Manci N, Panici PB. Laparoscopic excision of ovarian cysts: is the stripping technique a tissue-sparing procedure? Fertil Steril. 2002 Mar;77(3):609-14. doi: 10.1016/s0015-0282(01)03203-4.
PMID: 11872220BACKGROUNDAkamatsu N, Hirai T, Masaoka H, Sekiba K, Fujita T. [Ultrasonically guided puncture of endometrial cysts--aspiration of contents and infusion of ethanol]. Nihon Sanka Fujinka Gakkai Zasshi. 1988 Feb;40(2):187-91. Japanese.
PMID: 3283269BACKGROUNDNoma J, Yoshida N. Efficacy of ethanol sclerotherapy for ovarian endometriomas. Int J Gynaecol Obstet. 2001 Jan;72(1):35-9. doi: 10.1016/s0020-7292(00)00307-6.
PMID: 11146075BACKGROUNDKafali H, Eser A, Duvan CI, Keskin E, Onaran YA. Recurrence of ovarian cyst after sclerotherapy. Minerva Ginecol. 2011 Feb;63(1):19-24.
PMID: 21311417BACKGROUNDRaffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012 Sep;97(9):3146-54. doi: 10.1210/jc.2012-1558. Epub 2012 Jun 20.
PMID: 22723324RESULTBiacchiardi CP, Piane LD, Camanni M, Deltetto F, Delpiano EM, Marchino GL, Gennarelli G, Revelli A. Laparoscopic stripping of endometriomas negatively affects ovarian follicular reserve even if performed by experienced surgeons. Reprod Biomed Online. 2011 Dec;23(6):740-6. doi: 10.1016/j.rbmo.2011.07.014. Epub 2011 Jul 27.
PMID: 22019621RESULTYazbeck C, Madelenat P, Ayel JP, Jacquesson L, Bontoux LM, Solal P, Hazout A. Ethanol sclerotherapy: a treatment option for ovarian endometriomas before ovarian stimulation. Reprod Biomed Online. 2009 Jul;19(1):121-5. doi: 10.1016/s1472-6483(10)60055-7.
PMID: 19573300RESULTGarcia-Tejedor A, Castellarnau M, Ponce J, Fernandez ME, Burdio F. Ethanol sclerotherapy of ovarian endometrioma: a safe and effective minimal invasive procedure. Preliminary results. Eur J Obstet Gynecol Reprod Biol. 2015 Apr;187:25-9. doi: 10.1016/j.ejogrb.2015.02.004. Epub 2015 Feb 16.
PMID: 25739052RESULTSomigliana E, Berlanda N, Benaglia L, Vigano P, Vercellini P, Fedele L. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimullerian hormone level modifications. Fertil Steril. 2012 Dec;98(6):1531-8. doi: 10.1016/j.fertnstert.2012.08.009. Epub 2012 Sep 10.
PMID: 22975114RESULTGarcia-Tejedor A, Guevara-Peralta R, Martinez-Garcia JM, Corbalan S, Aguero M, Gomez-Romero M, Cararach M, Castellarnau M, Rodriguez M, Lou-Mercade AC, Costa L, Rodriguez MJ, Huguet E, Carreras M, Castel-Segui AB, Font-Roig M, Royo S, Sarasa N, Candas B, Perez-Carton S, Ortega C, Pla MJ, Ponce J. Ultrasound-guided ethanol sclerotherapy versus laparoscopic surgery for endometriomas: a randomized clinical trial in a real-world setting. Arch Gynecol Obstet. 2025 Dec;312(6):2199-2210. doi: 10.1007/s00404-025-08205-1. Epub 2025 Nov 4.
PMID: 41186685DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amparo Garcia-Tejedor, MDPhD
Hospital de Bellvitge. IDIBELL
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 31, 2018
First Posted
June 28, 2018
Study Start
June 5, 2018
Primary Completion
January 15, 2023
Study Completion
January 15, 2023
Last Updated
March 2, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share